Send feedback

ACTN2 p.Gln830Lys

c.2488C>A · rs145087599 · VCV2949521

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.7263 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000254%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.7263likely pathogenic
REVEL0.578indeterminate
SaProtLLR -10.40damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI<0.2all four deltas below 0.2 · C>T here scores Δ0.87 · evaluated, not missing
Constraint at this position
ConservationphyloP 7.7GERP 2.4, phastCons 1
Regional constrainto/e 0.90unconstrained · MANE · 25 kb · p 0.0054 · regional, not allelic
Overall
CADD25.7PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000254% European (non-Finnish) · 3/1,180,044 alleles
Filtering AF 6.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.9e-05%
Overall 0.000682% 11/1,614,078 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00781% 12,805
Remaining individualsnot grpmax-eligible 0.0048% 20,829
European (non-Finnish)grpmax 0.000254% 393,348

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ACTN2
Protein
p.Gln830Lys
Coding
c.2488C>A
MANE Select
NM_001103
dbSNP
rs145087599
Type
single nucleotide variant
Location
chr1:236761135 (GRCh38)
Gene constraint
LOEUF 0.432 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 84.88 · 18 PDB
Residue 830
an α-helix
Full ACTN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/actn2-p-gln830lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown